Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.709
+0.089 (14.29%)
At close: Jun 26, 2026, 4:00 PM EDT
0.745
+0.036 (5.14%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Humacyte Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Humacyte stock have an average target of 2.63, with a low estimate of 1.00 and a high estimate of 6.00. The average target predicts an increase of 271.15% from the current stock price of 0.71.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Humacyte stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 2 | 2 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $1 | Hold | Maintains | $1 | +41.12% | Jun 18, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $1.5 → $1.25 | Buy | Reiterates | $1.5 → $1.25 | +76.40% | Jun 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 | Buy | Reiterates | $4 | +464.49% | Jun 11, 2026 |
| Benchmark Co. | Benchmark Co. | Buy Maintains $1 → $2 | Buy | Maintains | $1 → $2 | +182.25% | Jun 1, 2026 |
| Barclays | Barclays | Buy Reiterates $1.5 | Buy | Reiterates | $1.5 | +111.69% | May 14, 2026 |
Financial Forecast
Revenue This Year
6.34M
from 2.04M
Increased by 211.26%
Revenue Next Year
26.31M
from 6.34M
Increased by 314.69%
EPS This Year
-0.35
from -0.26
EPS Next Year
-0.24
from -0.35
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.4M | 53.4M | |
| Avg | 6.3M | 26.3M | |
| Low | 4.4M | 11.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 311.1% | 741.7% | |
| Avg | 211.3% | 314.7% | |
| Low | 114.4% | 73.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.32 | -0.22 | |
| Avg | -0.35 | -0.24 | |
| Low | -0.37 | -0.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.